<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0000726'>Dementia</z:hpo> affects an estimated 10% of the population older than 65 years </plain></SENT>
<SENT sid="1" pm="."><plain>Because vascular and <z:chebi fb="23" ids="18059">lipid</z:chebi>-related mechanisms are thought to have a role in the pathogenesis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, we did an epidemiological study of the potential effect of HMGCoA (3 hydroxy-3methylglutaryl-<z:chebi fb="3" ids="15346">coenzyme A</z:chebi>) reductase inhibitors (<z:chebi fb="0" ids="35664">statins</z:chebi>) and other <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering agents on <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We used a nested case-control design with information derived from 368 practices which contribute to the UK-based General Practice Research Database </plain></SENT>
<SENT sid="3" pm="."><plain>The base study population included three groups of patients age 50 years and older: <z:hpo ids='HP_0000001'>all</z:hpo> individuals who had received <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering agents (LLAs); <z:hpo ids='HP_0000001'>all</z:hpo> individuals with a clinical diagnosis of untreated <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e>; and a randomly selected group of other individuals </plain></SENT>
<SENT sid="4" pm="."><plain>From this base population, <z:hpo ids='HP_0000001'>all</z:hpo> cases with a computer-recorded clinical diagnosis of <z:hpo ids='HP_0000726'>dementia</z:hpo> were identified </plain></SENT>
<SENT sid="5" pm="."><plain>Each case was matched with up to four controls derived from the base population on age, sex, practice, and index date of case </plain></SENT>
<SENT sid="6" pm="."><plain>FINDINGS: The study encompassed 284 cases with <z:hpo ids='HP_0000726'>dementia</z:hpo> and 1080 controls </plain></SENT>
<SENT sid="7" pm="."><plain>Among controls 13% had untreated <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e>, 11% were prescribed <z:chebi fb="0" ids="35664">statins</z:chebi>, 7% other LLAs, and 69% had no <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> or LLA exposure </plain></SENT>
<SENT sid="8" pm="."><plain>The relative risk estimates of <z:hpo ids='HP_0000726'>dementia</z:hpo> adjusted for age, sex, history of <z:hpo ids='HP_0001677'>coronary-artery disease</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, coronary-bypass surgery and <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>, smoking and body mass index for individuals with untreated <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> (odds ratio 0.72 [95% CI 0.45-1.14]), or treated with nonstatin LLAs (0.96 [0.47-1.97], was close to 1.0 and not significant compared with people who had no diagnosis of <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> or exposure to other <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering drugs </plain></SENT>
<SENT sid="9" pm="."><plain>The adjusted relative risk for those prescribed <z:chebi fb="0" ids="35664">statins</z:chebi> was 0.29 (0.13-0.63; p=0.002) </plain></SENT>
<SENT sid="10" pm="."><plain>INTERPRETATION: Individuals of 50 years and older who were prescribed <z:chebi fb="0" ids="35664">statins</z:chebi> had a substantially lowered risk of developing <z:hpo ids='HP_0000726'>dementia</z:hpo>, independent of the presence or absence of untreated <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e>, or exposure to nonstatin LLAs </plain></SENT>
<SENT sid="11" pm="."><plain>The available data do not distinguish between <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and other forms of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>